2023
DOI: 10.1016/j.molstruc.2022.134160
|View full text |Cite
|
Sign up to set email alerts
|

Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 40 publications
0
4
0
Order By: Relevance
“…Moreover, we validated the performance of PALM by ClusPro 40,41 and SnugDock 13 , which are widely accepted antibody validation tools [56][57][58][59] . PALM was able to generate antibody CDRH3 sequences targeting the stable peptide in the HR2 region of SARS-CoV-2.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, we validated the performance of PALM by ClusPro 40,41 and SnugDock 13 , which are widely accepted antibody validation tools [56][57][58][59] . PALM was able to generate antibody CDRH3 sequences targeting the stable peptide in the HR2 region of SARS-CoV-2.…”
Section: Discussionmentioning
confidence: 99%
“…The CypA/ CD147 interaction is a crucial route in some cancer types and is also necessary for the COVID-19 virus to infect the host cell. Thus, it is suggested that the designed peptide may prove to be an appealing treatment target for controlling different tumor types as well as COVID-19 infection (Maani et al, 2023). Melittin showed selective cytotoxicity against HER2-enriched breast cancer cell lines (MDA-MB-453 and SKBR3) and Triple Negative Breast Cancer (TNBC) cell lines (SUM 159 and SUM149), while exhibiting minimal cytotoxicity against normal cell lines (HDFa, and MCF 10A and MCF-12A cells) (Duffy et al, 2020).…”
Section: Bee Venommentioning
confidence: 99%
“…Moreover, MLT blocked the MMP pathway and inhibited caspase activity by intervening in the interaction between CD147 and its ligand cyclophilin A (CypA). The latest research reported that the C-terminal portion of MLT was fused to a TAT cell-penetrating peptide by the GGGS linker to construct the TM peptide, which could be bound to CD147 with sufficient binding energy to block the cyclophilin A/CD147 interaction [ 118 ] (Fig. 7 ).…”
Section: Targeted Delivery Strategies Of Mlt For Tumor Therapymentioning
confidence: 99%
“…C Coarse-grained simulation of the TM peptide interaction with the DOPC/DOPS model membrane after 1500 ns (yellow = water, red = protein, blue, pink, light gray = lipid). Reproduced with permission from [118]. Copyright 2023, Elsevier synergistic cytotoxicity as well as a better effect on controlling tumor growth than monotherapy [120].…”
Section: Aptamer-based Conjugationmentioning
confidence: 99%